Delhi's premier hospital Institute of Liver and Biliary Sciences and the Pasteur Institute of Paris today signed an MoU to cooperate with each other in clinical, academic and research initiatives.
This MoU provides for a strategic tie-up between the two institutes in research and knowledge-sharing in areas of liver regeneration, liver cancer and other related ailments.
Dr Shiv Sarin, Director of ILBS, hoped the collaboration would help develop cancer vaccines and support thousands of patients who cannot get donors for undergoing liver transplantation.
The Pasteur Institute has indicated its willingness to establish a joint research laboratory at ILBS.
Delhi Chief secretary S K Srivastava, who is also chairman of ILBS, hailed the initiative as a "landmark partnership" which could bring new treatment options for patients with liver diseases across the world.
The President of Institute Pasteur, Christian Brechot, assured of collaboration and transfer of technology for new discoveries and drug development in the field of liver failure and liver cancer.
The institute of Liver and Biliary Sciences is an autonomous super speciality, medical-cum-research institute for treatment of liver and biliary diseases under Delhi government.
It provided treatment to about 60,000 patients having liver and related diseases last year.
In February 2012, ILBS achieved the distinction of being the first autonomous super-speciality institute in the country to be awarded the prestigious "NABH Accreditation" by the National Accreditation Board in recognition of its compliance with the stringent national and international standards aimed towards patient safety and delivery of quality healthcare.
